Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Passage Bio Inc (NQ: PASG ) 0.7467 +0.0167 (+2.29%) Streaming Delayed Price Updated: 4:00 PM EDT, Aug 21, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Passage Bio Inc < Previous 1 2 3 4 5 Next > PASG Stock Earnings: Passage Bio Beats EPS for Q2 2024 August 08, 2024 PASG stock results show that Passage Bio beat analyst estimates for earnings per share the second quarter of 2024. Via InvestorPlace Passage Bio Reports Second Quarter 2024 Financial Results and Provides Recent Business Highlights August 08, 2024 From Passage Bio Via GlobeNewswire Passage Bio to Participate in Upcoming Investor Conferences August 06, 2024 From Passage Bio Via GlobeNewswire Passage Bio Out-licenses Three Pediatric Gene Therapy Programs to GEMMA Biotherapeutics and Enters New Research Collaboration August 01, 2024 From Passage Bio Via GlobeNewswire Recap: Passage Bio Q3 Earnings November 13, 2023 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday July 16, 2024 It's time to dive into the biggest pre-market stock movers as we check out all of the latest news worth reading about on Tuesday morning! Via InvestorPlace Passage Bio Announces Positive Feedback from FDA on Expansion of upliFT-D Trial of PBFT02 to Include FTD-C9orf72 Patients July 16, 2024 From Passage Bio Via GlobeNewswire Passage Bio to Present at Goldman Sachs 45th Annual Global Healthcare Conference June 05, 2024 From Passage Bio Via GlobeNewswire PASG Stock Earnings: Passage Bio Beats EPS for Q1 2024 May 14, 2024 PASG stock results show that Passage Bio beat analyst estimates for earnings per share the first quarter of 2024. Via InvestorPlace Passage Bio Reports First Quarter 2024 Financial Results and Provides Recent Business Highlights May 14, 2024 From Passage Bio Via GlobeNewswire Passage Bio to Present at Chardan’s 8th Annual Genetic Medicines and Cell Therapy Manufacturing Summit April 22, 2024 From Passage Bio Via GlobeNewswire PASG Stock Earnings: Passage Bio Beats EPS for Q4 2023 March 06, 2024 PASG stock results show that Passage Bio beat analyst estimates for earnings per share the fourth quarter of 2023. Via InvestorPlace Passage Bio Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Recent Business Highlights March 04, 2024 From Passage Bio Via GlobeNewswire Passage Bio to Participate in Upcoming Investor Conferences February 27, 2024 From Passage Bio Via GlobeNewswire 7 Analyst-Backed Stocks With Promising 10-Bagger Potential February 01, 2024 Although true 10-baggers are by nature extremely difficult to come by, these analyst-backed stocks may offer a decent shot. Via InvestorPlace Passage Bio to Present at Guggenheim Healthcare Talks 6th Annual Biotechnology Conference January 31, 2024 From Passage Bio Via GlobeNewswire 12 Health Care Stocks Moving In Friday's Pre-Market Session January 26, 2024 Via Benzinga 12 Health Care Stocks Moving In Monday's After-Market Session January 22, 2024 Via Benzinga 12 Health Care Stocks Moving In Wednesday's After-Market Session January 17, 2024 Via Benzinga 7 Nano-Cap Stocks That Pack a Serious Punch for Their Weight December 25, 2023 Although nano-cap stocks are super-risky just like stealing bases in baseball, there may be a time and place for extreme speculation. Via InvestorPlace 12 Health Care Stocks Moving In Thursday's Pre-Market Session December 21, 2023 Via Benzinga Why BlackBerry Shares Are Trading Lower By Over 5%; Here Are 20 Stocks Moving Premarket December 21, 2023 Shares of BlackBerry Limited (NYSE: BB) moved lower in pre-market trading following the release of third-quarter results. Via Benzinga Neurology-Focused Passage Bio Reveals Initial Data From Dementia Study, Outlines Strategic Priorities December 20, 2023 Passage Bio Inc (NASDAQ: PASG) announced initial safety and biomarker data from three Cohort 1 patients in the ongoing global Phase 1/2 upliFT-D clinical trial evaluating PBFT02, an adeno-associated... Via Benzinga 12 Health Care Stocks Moving In Wednesday's Pre-Market Session December 20, 2023 Via Benzinga Passage Bio Announces Promising Initial Data From Phase 1/2 Clinical Trial of PBFT02 in FTD-GRN and Updated Strategic Priorities December 20, 2023 From Passage Bio Via GlobeNewswire Passage Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4) November 17, 2023 From Passage Bio Via GlobeNewswire Monday.Com To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Tuesday November 14, 2023 Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page Via Benzinga Passage Bio Reports Third Quarter 2023 Financial Results and Provides Recent Business Highlights November 13, 2023 From Passage Bio Via GlobeNewswire 12 Health Care Stocks Moving In Friday's After-Market Session November 03, 2023 Via Benzinga Passage Bio to Present at Guggenheim’s 5th Annual Inflammation, Neurology & Immunology Conference October 30, 2023 From Passage Bio Via GlobeNewswire < Previous 1 2 3 4 5 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
